Synovial Osteochondromatosis
No Results
No Results
processing….
Synovial osteochondromatosis (SOC) is a benign condition characterized by synovial membrane proliferation (demonstrated in the images below) and metaplasia. The entity also is termed synovial chondromatosis. The synovial lining of a joint, bursa, or tendon sheath undergoes nodular proliferation, and fragments may break off from the synovial surface into the joint. [1] There, nourished by synovial fluid, the fragments may grow, calcify, or ossify. The intra-articular fragment may vary in size from a few millimeters to a few centimeters. [2, 3, 4, 5, 6, 7]
Malignant transformation of synovial chondromatosis to synovial chondrosarcoma (CHS) is recognized to be a rare event. In a study of 78 patients who presented with primary synovial chondromatosis, 5 went on to develop malignant change (incidence of 6.4%). The mean age at first diagnosis of synovial chondromatosis was 28 years, and the median time from original diagnosis to malignant transformation was 20 years (range, 2.7-39 years). [8]
The images below present a detailed view of SOC of the shoulder.
The degree of calcification varies, and calcification may be seen as a few calcific specks or as foci of frankly ossified bodies. [9] The fragments may be found free within the joint cavity, or they may be embedded within the proliferating synovium, which may extend into the surrounding soft tissues. The natural history of SOC entails gradual progression of disease, joint deterioration, and secondary osteoarthritis. Essentially, the disease is a benign process, and although studies in the literature have reported malignant transformation, this finding is decidedly unusual.
Radiographic findings are frequently diagnostic. CT scans and CT arthrograms also may be used, especially for demonstrating noncalcified intra-articular bodies. MRI usually helps establish the diagnosis, and the images demonstrate the true extent of the disease. Ultrasonographic examination may be used to investigate accessible joints.
Radiographs should be obtained first. [10, 11, 12, 13, 14] MRI scans should then be obtained preoperatively. When MRI is not readily available, CT arthrography may be performed.
Radiographs may not demonstrate noncalcified bodies. CT scans may not demonstrate the full extent of proliferating synovial disease. SOC may be confused with pigmented villonodular synovitis (PVNS) if only MRI scans are available, and plain radiographs may help in such cases.
Plain radiographs frequently show characteristic features, including multiple (usually >5) calcified or osseous bodies within the joint or bursa, as in the images below. When fragments are not calcified, intrasynovial fragments may not be seen on plain images, and arthrographic studies are required to demonstrate the bodies.
Pressure erosions (saucerization; as demonstrated in the image below) and cyst formation can be seen in adjacent bone, although this is more typical for joints with lax capsules, such as the hip. A similar observation may be found in patients with PVNS.
With plain radiography, differential diagnoses include degenerative joint disease in which osteophytes have broken off into the joint; however, SOC tends to have a larger number of bodies in the joint (usually >5). Other differential diagnoses include soft-tissue and intra-articular chondromas. In advanced stages of SOC, secondary degenerative changes are often observed.
CT scanning is rarely necessary to make a diagnosis, and the CT scan’s features are similar to findings on plain radiographs. CT scanning may show noncalcified bodies.
See the CT scans depicting synovial osteochondromatosis, below.
In synovial osteochondromatosis (SOC), T1-weighted and proton density–weighted images often demonstrate multiple rounded bodies that are isointense or hypointense relative to muscle. Some bodies demonstrate signal intensity (or lack of it) similar to that of cortical bone. [15]
See the magnetic resonance images depicting SOC, below.
Some bodies may lie free, and some are completely intra-articular, whereas others may be adherent to the synovial surface. Some bodies may be found deep in the synovial lining, embedded in adjacent soft tissue.
T2-weighted images may show areas of high signal intensity consistent with joint effusion and synovial thickening.
In a study of 144 patients with synovial chondromatosis of the temporomandibular joint evaluated by MRI, 3 lesion types were visualized: loose body (32.6%), homogeneous mass (49.3%), and a mixture of the two (18.1%). Bony evaluations included 4 stages of erosion: without erosion, chondral breakdown, bony absorption, and bony perforation. Of the bony perforations, 80% were homogeneous masses and 20% were mixed loose body/homogenous mass. [16]
The intravenous administration of a gadolinium-based contrast material usually enables the differentiation of joint effusion from hyperplastic synovium, which shows heterogeneous enhancement. Joint effusion may be hemorrhagic.
Gadolinium-based contrast agents have been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or magnetic resonance angiography scans.
NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness.
When the presence of calcification is ambiguous, plain radiographs are useful adjuncts to MRI scans for establishing the diagnosis.
On MRI scans, SOC may appear somewhat similar to pigmented villonodular synovitis (PVNS), but the 2 conditions are easily differentiated by using plain radiographs.
The distinguishing feature of SOC is calcification, which appears as signal voids in the synovium. This finding is optimally visualized when the intra-articular fragments are calcified.
Radionuclide studies (see the image below) may be obtained when the plain radiographic features are not clear. The affected areas usually show increased radionuclide uptake on technetium-99m bone scans. [17]
Garner HW, Bestic JM. Benign synovial tumors and proliferative processes. Semin Musculoskelet Radiol. 2013 Apr. 17(2):177-8. [Medline].
Pau M, Bicsák A, Reinbacher KE, Feichtinger M, Kärcher H. Surgical treatment of synovial chondromatosis of the temporomandibular joint with erosion of the skull base: a case report and review of the literature. Int J Oral Maxillofac Surg. 2013 Dec 3. [Medline].
Reed LS, Foster MD, Hudson JW. Synovial chondromatosis of the temporomandibular joint: a case report and literature review. Cranio. 2013 Oct. 31(4):309-13. [Medline].
Zhu Y, Zheng C, Deng Y, Zhang Y, Hu X. Arthroscopic surgery for removal of 112 loose bodies of synovial chondromatosis of the temporomandibular joint. J Craniofac Surg. 2013 Nov. 24(6):2166-9. [Medline].
Dimnjakovic D, Bojanic I, Mahnik A, Smoljanovic T. Synovial chondromatosis of the elbow. Coll Antropol. 2013 Jun. 37(2):633-8. [Medline].
Fukui K, Kaneuji A, Amaya S, Matsumoto T. Synovial osteochondromatosis of the hip with femoroacetabular impingement and osteoarthritis: a case report. J Orthop Surg (Hong Kong). 2013 Apr. 21(1):117-21. [Medline].
Ho YY, Choueka J. Synovial chondromatosis of the upper extremity. J Hand Surg Am. 2013 Apr. 38(4):804-10. [Medline].
Evans S, Boffano M, Chaudhry S, Jeys L, Grimer R. Synovial chondrosarcoma arising in synovial chondromatosis. Sarcoma. 2014. 2014:647939. [Medline]. [Full Text].
Matsumura Y, Nomura J, Nakanishi K, Yanase S, Kato H, Tagawa T. Synovial chondromatosis of the temporomandibular joint with calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). Dentomaxillofac Radiol. 2012 Dec. 41(8):703-7. [Medline]. [Full Text].
Goldberg RP, Genant HK. Calcified bodies in popliteal cysts: a characteristic radiographic appearance. AJR Am J Roentgenol. 1978 Nov. 131(5):857-9. [Medline].
Kenan S, Abdelwahab IF, Klein MJ, et al. Case report 817: synovial chondrosarcoma secondary to synovial chondromatosis. Skeletal Radiol. 1993 Nov. 22(8):623-6. [Medline].
Adams ME, Saifuddin A. Characterisation of intra-articular soft tissue tumours and tumour-like lesions. Eur Radiol. 2007 Apr. 17(4):950-8. [Medline].
Prager RJ, Mall JC. Arthrographic diagnosis of synovial chondromatosis. Am J Roentgenol. 1976 Aug. 127(2):344-6. [Medline].
Noyek AM, Holgate RC, Fireman SM, et al. The radiologic findings in synovial chondromatosis (chondrometaplasia) of the temporomandibular joint. J Otolaryngol Suppl. 1977. 3:45-8. [Medline].
Ontell F, Greenspan A. Chondrosarcoma complicating synovial chondromatosis: findings with magnetic resonance imaging. Can Assoc Radiol J. 1994 Aug. 45(4):318-23. [Medline].
Chen MJ, Yang C, Qiu YT, Jiang Q, Shi HM, Wei WB. Synovial chondromatosis of the tempromandibular joint: Relationship between MRI information and potential aggressive behavior. J Craniomaxillofac Surg. 2015 Apr. 43(3):349-54. [Medline].
Zimmerman C, Sayegh V. Roentgen manifestations of synovial osteochondromatosis. Am J Roentgenol Radium Ther Nucl Med. 1960 Apr. 83:680-6. [Medline].
Reed LS, Foster MD, Hudson JW. Synovial chondromatosis of the temporomandibular joint: a case report and literature review. Cranio. 2013 Oct. 31(4):309-13. [Medline].
Johnny U V Monu, MD, MS Professor of Imaging Sciences and Orthopedics, University of Rochester School of Medicine and Dentistry; Head and Program Director, Musculoskeletal Radiology, Department of Radiology, University of Rochester Strong Memorial Medical Center
Johnny U V Monu, MD, MS is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Javier Beltran, MD Chair, Department of Radiology, Maimonides Medical Center
Disclosure: Nothing to disclose.
Felix S Chew, MD, MBA, MEd Professor, Department of Radiology, Vice Chairman for Academic Innovation, Section Head of Musculoskeletal Radiology, University of Washington School of Medicine
Felix S Chew, MD, MBA, MEd is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America
Disclosure: Nothing to disclose.
David S Levey, MD Musculoskeletal and Neurospinal Forensic Radiologist; President, David S Levey, MD, PA, San Antonio, Texas
David S Levey, MD is a member of the following medical societies: American Roentgen Ray Society, Bexar County Medical Society, Forensic Expert Witness Association, International Society of Forensic Radiology and Imaging, International Society of Radiology, Technical Advisory Service for Attorneys, Texas Medical Association
Disclosure: Nothing to disclose.
The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Mayumi Oka, MD,to the development and writing of this article.
Synovial Osteochondromatosis
Research & References of Synovial Osteochondromatosis|A&C Accounting And Tax Services
Source
0 Comments